Highlights
A collection of news and information related to Lilly Eli & Co published by Tribune Company sources.
Displaying items 1-12 of 60
» View newsday.com items only
1
2
3
4
5
Next >
-
Artist's Works Inspired By Husband's Cancer Death
The AdvocateIf one were to use an X-ray machine to study an artwork by Nash Hyon, all kinds of things would show up under the waxy surface. Sometimes there are renderings of body parts, lung and brain scans being recurring themes. There are references to chemical...Tags: Paul Newman, Westport, Depression, Cancer, Diseases
-
Artist's works inspired by husband's cancer death
The Advocate of StamfordIf an X-ray machine were to study one of Nash Hyon's artworks, it would find all kinds of things underneath the waxy surface. Sometimes there are renderings of body parts, lung and brain scans being recurring themes. There are references to the chemical...Tags: Paul Newman, Family, Depression, Cancer, Homes
-
Chronic-pain drug bid withdrawn
Drugmaker Eli Lilly and Co. withdrew a bid to have its antidepressant Cymbalta approved as a treatment for chronic pain; Eli Lilly said Friday it will apply in 2009. The old applications included data from two trials in low back pain and one in chronic...Tags: Pain, Migraine, Medical Conditions
-
Lilly withdraws Cymbalta chronic pain application, plans to resubmit request in early 2009
INDIANAPOLIS (AP) _ Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009. Eli Lilly had filed a supplemental new drug...Tags: Pain, Health Organizations, Medical Conditions, Migraine
-
Target, Yahoo, Ford, Eli Lilly, Arcelor Mittal among big movers Friday
NEW YORK (AP) _ Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE New York & Co., up 51 cents at $1.88 During the next twelve months, the women's clothing retailer plans to buy...Tags: Chesapeake Energy Corporation, Target Corporation, New York Stock Exchange, General Motors Corp., Stock Broking
-
In job search, Web can work for you
Looking for work in an economic downturn can be challenging, but it's easier today than it used to be - and that may hold truest of all for the retired set. Those who are in or near retirement and are looking for work can find online resources that may...Tags: Alzheimer's Disease, Internal Revenue Service, Employees, Financial Markets, Diseases
-
The Starting Place breakfast raises $57,000
A marketing publication of the Sun-Sentinel CompanyA fundraising breakfast, themed "New Beginnings at the Starting Place," raised more than $57,000 to assist in rebuilding of The Starting Place, Inc., an organization which helps thousands of adolescents every year who are affected by substance abuse and...Tags: BankAtlantic, Fort Lauderdale, Miami (Miami-Dade, Florida), Broward County, Financial Planning
-
Eli Lilly takes $1.4-billion charge related to Zyprexa probe
The Associated PressEli Lilly & Co. will take a big bite out of its third-quarter earnings with a $1.4-billion charge related to a government investigation over marketing practices for the antipsychotic medicine Zyprexa. The drug maker said Tuesday that it would take a...Tags: Pennsylvania
-
The quest for cancer-preventing drugs
Los Angeles Times Staff WriterAt 66 years old, Vincent Motyl has the gravelly voice and rumbling laugh of a man who's spent much of his life in a halo of cigarette smoke. He grew up amid the industrial soot of Pittsburgh in a houseful of smokers and started a two-pack-a-day habit at...Tags: Osteoporosis, Prescription Drugs, Pharmaceuticals, Research, Medical Specialization
-
Buyout details
ASSOCIATED PRESSIndianapolis-based Eli Lilly & Co. is buying ImClone Systems Inc., the biotechnology company controlled by billionaire Carl Icahn. WHO GETS WHAT •Lilly would boost its cancer portfolio, which contains the drugs Alimta and Gemzar, by gaining...Tags: Bristol Myers Squibb Company, Western Medicines, Medicine, Biotechnology, ImClone Systems Incorporated
-
Lilly looking to its future in $6 billion ImClone deal
From Chicago Tribune news servicesEli Lilly & Co.'s winning bid of more than $6 billion for cancer drug-maker ImClone Systems Inc. means a billion-dollar payday for former rival bidder Bristol-Myers Squibb Co. and vindication for billionaire investor and ImClone Chairman Carl Icahn....Tags: Bristol Myers Squibb Company, Western Medicines, Leveraged Buyouts, Patents, Copyrights and Trademarks, Pharmaceuticals
-
Florida, 32 states reach settlement with Eli Lilly
Sentinel Staff WriterFlorida Attorney General Bill McCollum announced today that Florida and 32 other states have reached a record-setting $62 million settlement with Eli Lilly and Co. over charges that the company improperly marketed the prescription drug Zyprexa. The...Tags: Trials, Lawyers, Justice System, Pharmaceuticals, Bill McCollum
Dec 1, 2008
|Story| Hartford Courant
Nov 29, 2008
|Story| Associated Press
Nov 29, 2008
|Story| Hampton Roads Daily Press
Nov 28, 2008
|Story| Associated Press
Nov 28, 2008
|Story| Associated Press
Nov 8, 2008
|Story| Newsday
Nov 5, 2008
|Story| South Florida Sun-Sentinel
Oct 22, 2008
|Story| Los Angeles Times
Oct 20, 2008
|Story| Los Angeles Times
Oct 7, 2008
|Story| Chicago Tribune
Oct 7, 2008
|Story| Chicago Tribune
Oct 7, 2008
|Story| Orlando Sentinel


